{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:35:51Z","timestamp":1781624151466,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018255","name":"GLA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jmgm.2026.109352","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:29:32Z","timestamp":1773250172000},"page":"109352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Decoding structural and dynamic determinants of Tropifexor-FXR binding: A comprehensive computational analysis"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6147-3516","authenticated-orcid":false,"given":"Suman","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5478-626X","authenticated-orcid":false,"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109352_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"185 18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jmgm.2026.109352_bib2","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3390\/ijms24032408","article-title":"Role of FXR in renal physiology and kidney diseases","volume":"24","author":"Guo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109352_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jmgm.2026.109352_bib4","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1530\/EJE-20-1410","article-title":"Mechanisms in endocrinology: FXR signalling: a novel target in metabolic diseases","volume":"184","author":"Sonne","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jmgm.2026.109352_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","article-title":"FXR modulators for enterohepatic and metabolic diseases","volume":"28","author":"Wang","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jmgm.2026.109352_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/164_2019_236","article-title":"Bile acid-activated receptors: a review on FXR and other nuclear receptors","volume":"256","author":"Shin","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109352_bib7","article-title":"Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109352_bib8","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.1074\/jbc.RA118.004652","article-title":"Ligand binding and heterodimerization with retinoid X receptor (RXR) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding","volume":"293","author":"Wang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2026.109352_bib9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jmgm.2026.109352_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BST20210658","article-title":"Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders","volume":"50","author":"Molinaro","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jmgm.2026.109352_bib11","series-title":"Drug Transport in the Liver","first-page":"245","author":"Ferslew","year":"2014"},{"key":"10.1016\/j.jmgm.2026.109352_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.875593","article-title":"Reduced peroxisome proliferator-activated receptor-\u03b1 and bile acid nuclear receptor NR1H4\/FXR may affect the hepatic immune microenvironment of biliary atresia","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmgm.2026.109352_bib13","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3390\/cells10081846","article-title":"Farnesoid X receptor as target for therapies to treat cholestasis-induced liver injury","volume":"10","author":"Petrescu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jmgm.2026.109352_bib14","first-page":"1","article-title":"Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer","volume":"21 2","author":"Girisa","year":"2021","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.jmgm.2026.109352_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111543","article-title":"Pleiotropic roles of FXR in liver and colorectal cancers","volume":"543","author":"Huang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jmgm.2026.109352_bib16","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1038\/s41598-022-12850-w","article-title":"FXR expression in rats of hilar cholangiocarcinoma","volume":"12","author":"yu Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109352_bib17","first-page":"1","article-title":"Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation","volume":"161 16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib18","first-page":"2464","article-title":"Obeticholic acid for primary biliary cholangitis","volume":"10","author":"Floreani","year":"2022","journal-title":"Biomed"},{"key":"10.1016\/j.jmgm.2026.109352_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17512433.2021.1884068","article-title":"An update on drug development for the treatment of nonalcoholic fatty liver disease \u2013 from ongoing clinical trials to future therapy","volume":"14","author":"Rau","year":"2021","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109352_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/164_2019_232","article-title":"Nonsteroidal FXR ligands: current status and clinical applications","volume":"256","author":"Gege","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109352_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2021","journal-title":"Process"},{"key":"10.1016\/j.jmgm.2026.109352_bib22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.bbrc.2020.10.039","article-title":"Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor","volume":"534","author":"Jiang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/acs.jpcb.2c06325","article-title":"Deciphering the structural determinants critical in attaining the FXR partial agonism","volume":"127","author":"Kumari","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2026.109352_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmgm.2026.109352_bib25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109352_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jcc.24660","article-title":"CHARMM-GUI 10 years for biomolecular modeling and simulation","volume":"38","author":"Jo","year":"2017","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109352_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2026.109352_bib28","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109352_bib29","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jmgm.2026.109352_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jmgm.2026.109352_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jmgm.2026.109352_bib32","author":"Dias"},{"key":"10.1016\/j.jmgm.2026.109352_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109421","article-title":"Evaluation of N-palmitoylethanolamine (PEA) binding to nuclear receptors through docking and molecular dynamics studies","volume":"184","author":"Frikha","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2026.109352_bib34","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109352_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00941484","article-title":"A steepest-descent method for optimization of mechanical systems","volume":"19","author":"Haug","year":"1976","journal-title":"J. Optim. Theor. Appl."},{"key":"10.1016\/j.jmgm.2026.109352_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/acs.jpca.8b09082","article-title":"New method for constant- NPT molecular dynamics","volume":"123","author":"Kim","year":"2019","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jmgm.2026.109352_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1063\/1.1376628","article-title":"Comparison of thermostatting mechanisms in NVT and NPT simulations of decane under shear","volume":"115","author":"Delhommelle","year":"2001","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109352_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/acs.jcim.0c01360","article-title":"CHARMM-GUI supports hydrogen mass repartitioning and different protonation states of phosphates in lipopolysaccharides","volume":"61","author":"Gao","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109352_bib39","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1038\/s41467-019-13768-0","article-title":"Definition of functionally and structurally distinct repressive states in the nuclear receptor PPAR\u03b3","volume":"101 10","author":"Heidari","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib40","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/ct5010406","article-title":"Long-time-step molecular dynamics through hydrogen mass repartitioning","volume":"11","author":"Hopkins","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2026.109352_bib41","doi-asserted-by":"crossref","DOI":"10.1063\/1.2779878","article-title":"On the calculation of velocity-dependent properties in molecular dynamics simulations using the leapfrog integration algorithm","volume":"127","author":"Cuendet","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109352_bib42","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jmgm.2026.109352_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2026.109352_bib44","series-title":"Proc. 15th Python Sci. Conf.","first-page":"98","article-title":"MDAnalysis: a python package for the rapid analysis of molecular dynamics simulations","author":"Gowers","year":"2019"},{"key":"10.1016\/j.jmgm.2026.109352_bib45","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109352_bib46","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2026.109352_bib47","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.100.020603","article-title":"Well-tempered metadynamics: a smoothly converging and tunable free-energy method","volume":"100","author":"Barducci","year":"2008","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.jmgm.2026.109352_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41592-019-0506-8","article-title":"Promoting transparency and reproducibility in enhanced molecular simulations","volume":"16","author":"Bonomi","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jmgm.2026.109352_bib49","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cpc.2009.05.011","article-title":"PLUMED: a portable plugin for free-energy calculations with molecular dynamics","volume":"180","author":"Bonomi","year":"2009","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","article-title":"Plumed 2: new feathers for an old bird","volume":"185","author":"Tribello","year":"2014","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib51","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1021\/acs.jpcb.9b02883","article-title":"In silico reoptimization of binding affinity and drug-resistance circumvention ability in kinase inhibitors: a case study with RL-45 and src kinase","volume":"123","author":"Koneru","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2026.109352_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.933676","article-title":"The role of conformational dynamics and allostery in the control of distinct efficacies of agonists to the glucocorticoid receptor","volume":"9","author":"Shi","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmgm.2026.109352_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.658312","article-title":"Conformational characterization of the Co-Activator binding site revealed the mechanism to achieve the bioactive state of FXR","volume":"8","author":"Kumari","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmgm.2026.109352_bib54","article-title":"When two become one: conformational changes in FXR\/RXR heterodimers bound to steroidal antagonists","volume":"18","author":"D\u00edaz-Holgu\u00edn","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2026.109352_bib55","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1039\/C5MB00137D","article-title":"Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening","volume":"11","author":"Sindhu","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jmgm.2026.109352_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-87061-w","article-title":"Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs)","volume":"11","author":"Slominski","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109352_bib57","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.bmcl.2008.06.073","article-title":"Conformationally constrained farnesoid X receptor (FXR) agonists: naphthoic acid-based analogs of GW 4064","volume":"18","author":"Akwabi-Ameyaw","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2026.109352_bib58","article-title":"BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination","volume":"6","author":"Jung","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmgm.2026.109352_bib59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbrc.2004.12.095","article-title":"TRRAP as a hepatic coactivator of LXR and FXR function","volume":"327","author":"Unno","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2026.109352_bib60","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.7b00907","article-title":"Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)","volume":"60","author":"Tully","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T10:42:01Z","timestamp":1775385721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"alternative-id":["S1093326326000781"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109352","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding structural and dynamic determinants of Tropifexor-FXR binding: A comprehensive computational analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109352"}}